We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Healthcare 7.71%
3 Consumer Discretionary 6.84%
4 Financials 6.55%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICFI icon
3351
ICF International
ICFI
$1.59B
$16K ﹤0.01%
162
-2,537
-94% -$276K
JMIA
3352
Jumia Technologies
JMIA
$772M
$16K ﹤0.01%
5,020
-447
-8% -$2.02K
JOBY icon
3353
Joby Aviation
JOBY
$7.83B
$16K ﹤0.01%
4,857
-15,366
-76% -$62.3K
OPLN
3354
Openlane
OPLN
$4.36B
$16K ﹤0.01%
1,174
-7,372
-86% -$98.8K
KC
3355
Kingsoft Cloud Holdings
KC
$3.51B
$16K ﹤0.01%
4,175
-17,937
-81% -$51.5K
KOS icon
3356
Kosmos Energy
KOS
$1.51B
$16K ﹤0.01%
2,455
-66,321
-96% -$414K
LEGH icon
3357
Legacy Housing
LEGH
$698M
$16K ﹤0.01%
845
-1,097
-56% -$19.3K
LWAY icon
3358
Lifeway Foods
LWAY
$395M
$16K ﹤0.01%
2,981
+2,199
+281% +$13.7K
MFA
3359
MFA Financial
MFA
$926M
$16K ﹤0.01%
1,602
-2,680
-63% -$26.9K
MXCT icon
3360
MaxCyte
MXCT
$141M
$16K ﹤0.01%
2,964
-17,712
-86% -$109K
NMIH icon
3361
NMI Holdings
NMIH
$3.44B
$16K ﹤0.01%
782
-21,310
-96% -$446K
ONDS icon
3362
Ondas Inc
ONDS
$5.27B
$16K ﹤0.01%
10,197
+6,126
+150% +$18K
OPAD icon
3363
Offerpad Solutions
OPAD
$21.5M
$16K ﹤0.01%
235
+180
+327% +$20.8K
ORMP icon
3364
Oramed Pharmaceuticals
ORMP
$186M
$16K ﹤0.01%
1,306
+1,106
+553% +$8.6K
ORRF icon
3365
Orrstown Financial Services
ORRF
$852M
$16K ﹤0.01%
687
-344
-33% -$8.79K
PACB icon
3366
Pacific Biosciences
PACB
$357M
$16K ﹤0.01%
1,876
-74,575
-98% -$643K
PLPC icon
3367
Preformed Line Products
PLPC
$2.27B
$16K ﹤0.01%
198
-1,695
-90% -$140K
PSN icon
3368
Parsons
PSN
$5.12B
$16K ﹤0.01%
341
-1,404
-80% -$64.7K
QLC icon
3369
FlexShares US Quality Large Cap Index Fund
QLC
$1.05B
$16K ﹤0.01%
377
SGA icon
3370
Saga Communications
SGA
$62.1M
$16K ﹤0.01%
670
+487
+266% +$12K
SLNO
3371
DELISTED
Soleno Therapeutics
SLNO
$16K ﹤0.01%
7,952
+7,090
+823% +$8.82K
SMBC icon
3372
Southern Missouri Bancorp
SMBC
$845M
$16K ﹤0.01%
335
-205
-38% -$10.3K
SRDX
3373
DELISTED
Surmodics
SRDX
$16K ﹤0.01%
461
-4,416
-91% -$148K
TELA icon
3374
TELA Bio
TELA
$28.9M
$16K ﹤0.01%
1,352
-2,010
-60% -$18K
TPB icon
3375
Turning Point Brands
TPB
$1.75B
$16K ﹤0.01%
732
-2,883
-80% -$61.3K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.